Navigation Links
Baylor study finds common fire retardant harmful to aquatic life
Date:5/24/2011

A new study by Baylor University environmental health researchers found that zebra fish exposed to several different technical mixtures of polybrominated diphenyl ethers (PBDEs) a common fire retardant during early development can cause developmental malformations, changes in behavior and death.

The study will appear in the June issue of the journal Environmental Toxicology and Chemistry and is the first to test multiple PBDE mixtures for changes in behavior, physical malformations and mortality on zebra fish.

PBDEs are found in many common household products from blankets to couches to food wrappers. Lab tests have shown that PBDEs have been found in human breast milk and cord blood. Previous studies have showed children with high levels of PBDEs in their umbilical cord at birth scored lower on tests between one and six years of age. In 2006, the state of California started prohibiting the use of PBDEs.

The family of PBDEs consists of more than 200 possible substances, which are called congeners. Congeners are considered low if they average between 1 to 5 bromine atoms per molecule.

The Baylor researchers tested six PBDE congeners for developmental effects on embryonic zebra fish. Changes in behavior, physical malformations and mortality were recorded daily for seven days.

The results showed:

  • Lower brominated congeners were more toxic than higher brominated congeners.

  • Embryos were most sensitive to two particular types of PBDE exposures, the two lowest brominated congeners of the six tested. Both induced a curved body axis and eventually death.

  • In all, four of the six congeners tested caused developmental malformations, such as a curved body axis and pulmonary edema. Five of the six caused alterations in behaviors, such as decreased swimming rates and increased spontaneous movement in the embryo.

"While most PBDEs have either been banned or
'/>"/>

Contact: Matt Pene
Matt_Pene@baylor.edu
254-710-4656
Baylor University
Source:Eurekalert

Page: 1 2

Related biology news :

1. Baylor researchers unravel mystery of DNA conformation
2. Happy guys finish last, says new study on sexual attractiveness
3. Genetic study clarifies evolutionary origin of elusive montane red fox
4. A study will enable the survival and growth of the 3 development phases of the European eel
5. 5 UH graduates receive NSF fellowships for further study
6. Study Shows Sutro Biopharmas Biochemical Protein Synthesis Technology Enables Rapid Production and Scale-Up of Biopharmaceuticals
7. New study predicts risk of wetland habitat loss in southern United States
8. Greenhouse ocean study offers warning for future
9. Rigorous study confirms video game playing increases food intake in teens
10. Study reveals need for personalized approach in treatment of AML
11. Study finds therapies using induced pluripotent stem cells could encounter immune rejection problems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/19/2015)... Conn. , March 19, 2015  NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce market, announces ... in a news clip that aired this week on ... ) . In a segment "The Next Great ... wallet ,a new way to pay, and ,a really big ...
(Date:3/17/2015)... MedNet Solutions , a global ... management systems, is pleased to announce that company ... in Clinical Trials Southeast conference – March 24-25 ... forum for MedNet to showcase iMedNet , ... eClinical technology platform. We strongly encourage ...
(Date:3/17/2015)... YORK , March 17, 2015  MecklerMedia ... the largest exhibition for service robots ever held ... RoboUniverse takes place on May 11-13, 2015 at ... and exhibitors for the event include: Acorn Product ... Control; EZ-Robot; Infranor; Kinova Robotics; Littler; NewBotic Corporation; ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 2NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 3Connect With MedNet Solutions At Outsourcing In Clinical Trials Southeast 2MecklerMedia's RoboUniverse New York Announces Sponsors and Exhibitors, May 11-13, 2015 2
... Purdue University researchers are collaborating with Chrysler LLC in ... from a contaminated site in north-central Indiana. The ... a former oil storage facility near Kokomo, Ind., this ... been shown to be capable of absorbing trichloroethylene, or ...
... -- Rice University bioengineer Jennifer West is being recognized ... scientific honors, the O,Donnell Award from The Academy of ... O,Donnell Awards, given for excellence in medical, scientific and ... an inscribed statue. West, a pioneer in the field ...
... Ala. A drug originally used to treat iron ... heal and re-grow injured bones, according to researchers at ... researchers injected the drug deferoxamine (DF), which is designed ... found DF triggered the growth of new blood vessels, ...
Cached Biology News:Fighting pollution the poplar way: Trees to clean up Indiana site 2Fighting pollution the poplar way: Trees to clean up Indiana site 3Rice's West honored as one of Texas' best researchers 2Rice's West honored as one of Texas' best researchers 3New treatment boosts bone healing and regrowth 2
(Date:4/23/2015)... 23, 2015  Cryoport, Inc. (OTCBB: CYRX) ("Company"), ... for the life sciences industry, today announced that ... solutions within the animal husbandry market by signing ... support the shipment of equine semen for artificial ... Stallions. Animal husbandry is a multi-billion ...
(Date:4/23/2015)... -- Prospects for Leading Companies in OTC, ...   We predict the global healthcare packaging ... 2015 and will grow at a CAGR of 6.3% between ... the world and increasing functional requirements for healthcare packaging products ... healthcare packaging market. A global ageing population, changing ...
(Date:4/23/2015)... April 23, 2015 Proove ... Personalized Medicine, is excited to announce the launch ... . This profile assesses 62 genetic variations to ... information for commonly prescribed non-opioid pain medications, namely ... Neurontin), alprazolam (brand name Xanax) and acetaminophen (brand ...
(Date:4/23/2015)... YORK , April 23, 2015  Propanc ... stage healthcare company, focuses on the development of ... cancer. The company lead product includes PRP, a ... trypsinogen and chymotrypsinogen, as well as the enzyme ... is also developing a combination of anti-cancer agents ...
Breaking Biology Technology:Cryoport to Support the Equine Animal Husbandry Market Through Agreement with Yancey Farms 2Cryoport to Support the Equine Animal Husbandry Market Through Agreement with Yancey Farms 3Healthcare Packaging Market Forecast 2015-2025 2Healthcare Packaging Market Forecast 2015-2025 3Healthcare Packaging Market Forecast 2015-2025 4Healthcare Packaging Market Forecast 2015-2025 5Healthcare Packaging Market Forecast 2015-2025 6Healthcare Packaging Market Forecast 2015-2025 7Healthcare Packaging Market Forecast 2015-2025 8Healthcare Packaging Market Forecast 2015-2025 9Healthcare Packaging Market Forecast 2015-2025 10Proove Biosciences Launches World’s First Test to Predict Responders to Commonly Prescribed Non-Opioid Pain Medications 2Proove Biosciences Launches World’s First Test to Predict Responders to Commonly Prescribed Non-Opioid Pain Medications 3Early Stage BioTech offers Plenty of Risk; Propanc Health Group Analyst Brief Issued by BrokerBank Securities, Inc. 2
... Complete Genomics Inc.,a newly launched, third-generation human genome ... Annual BIO Investor Forum,which will be held in San ... president and chief executive officer of,Complete Genomics, will present ... Room of the Palace Hotel, located at 2 New ...
... Arena Pharmaceuticals,Inc. (Nasdaq: ARNA ) announced today that ... Conference on October 28, 2008 at 2:00 p.m.,Pacific Time ... in La,Jolla, California. Jack Lief, Arena,s President and Chief ... company, including its,clinical development and discovery programs., A ...
... demonstrated that low dose sublingual Intermezzo(R), used at ... significantly shortened time to ... Oct. 22 Transcept,Pharmaceuticals, Inc., a privately-held specialty pharmaceutical ... safety and efficacy of,its lead product candidate, Intermezzo(R) (zolpidem ...
Cached Biology Technology:Arena Pharmaceuticals to Present at the BIOCOM Investor Conference 2Arena Pharmaceuticals to Present at the BIOCOM Investor Conference 3Clinical Study of Intermezzo(R) for the Treatment of Middle of the Night Awakening Published in SLEEP 2Clinical Study of Intermezzo(R) for the Treatment of Middle of the Night Awakening Published in SLEEP 3Clinical Study of Intermezzo(R) for the Treatment of Middle of the Night Awakening Published in SLEEP 4Clinical Study of Intermezzo(R) for the Treatment of Middle of the Night Awakening Published in SLEEP 5Clinical Study of Intermezzo(R) for the Treatment of Middle of the Night Awakening Published in SLEEP 6
... The Rapid-Screen cDNA Library Panels were designed ... three sets of PCRs to identify the ... is performed in a 96-well "Master Plate," ... 5,000 clones. Having identified the positive well(s) ...
... The Rapid-Screen cDNA Library Panels were designed ... three sets of PCRs to identify the ... is performed in a 96-well "Master Plate," ... 5,000 clones. Having identified the positive well(s) ...
... cDNA Library Panels were designed for full-length ... of PCRs to identify the desired cDNA ... in a 96-well "Master Plate," where each ... Having identified the positive well(s) by gel ...
... a modification of the procedure of ... 11 , 1055 (1969). ... an A 260 of 1.0 ... cm light path). Physical Form: lyophilized ...
Biology Products: